Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-008443
Filing Date
2025-01-23
Accepted
2025-01-23 18:30:04
Documents
1
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 10554
  Complete submission text file 0000950170-25-008443.txt   12147
Mailing Address C/O CREDIT SUISSE 1ST BOSTON PRV EQY 11 MADISON AVENUE NEW YORK NY 10010
Business Address
HUNT RONALD (Reporting) CIK: 0001247851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 25551234

Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)